The biomarkers selected for the panel include tumor necrosis factor–α (TNF-α), interleukin-6 (IL-6), and IL-8, which are elevated in wound fluids obtained from nonhealing ulcers as compared to healing ulcers (16–18). The gene discussed is TNF; the disease is ulcer disease.